RWM
FENC icon

Raffa Wealth Management’s Fennec Pharmaceuticals FENC Stock Holding History

Raffa Wealth Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-36
Closed -$224 – 1104
2021
Q1 		$224 Hold
36
– – ﹤0.01% 1083
2020
Q4 		$268 Buy
+36
New +$274 ﹤0.01% 891

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
DCM
DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Raffa Wealth Management's FENC Position: Q2 2021 in Review

Raffa Wealth Management sold out of Fennec Pharmaceuticals (FENC) in Q2 2021, closing a stake of 36 shares — an estimated $224 sold.

Raffa Wealth Management first reported a position in FENC in Q4 2020 and held it in 2 quarters. The position peaked at $268 in Q4 2020. 39 funds tracked by Wall St. Rank hold FENC as of Q2 2021.

  • Raffa Wealth Management reported no remaining Fennec Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Raffa Wealth Management sold 36 Fennec Pharmaceuticals shares in Q2 2021, an estimated $224.
  • Raffa Wealth Management first reported a position in Fennec Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • Raffa Wealth Management's Fennec Pharmaceuticals position peaked at $268 in Q4 2020.
  • 39 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2021.

Based on Raffa Wealth Management's 13F filing for Q2 2021, filed 27 Jul 2026.